Insider · CIK 0001728741

Xu Stella

Reports to the SEC for 4 companies · GRAND CAYMAN, E9

sec.gov

Transactions

Companies

Filings

CIK

0001728741

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-05-31	DSGNDesign Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2022-06-15	DSGNDesign Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2022-03-22	DSGNDesign Therapeutics, Inc.S Sale	Director	SSale	−1,455 sh	$18.63	−$27.1K	4,129,950
2022-03-21	DSGNDesign Therapeutics, Inc.S Sale	Director	SSale	−24K sh	$19.01	−$456K	4,131,405
2022-03-18	DSGNDesign Therapeutics, Inc.S Sale	Director	SSale	−552K sh	$19.04	−$10.5M	4,168,605
2022-03-18	DSGNDesign Therapeutics, Inc.S Sale	Director	SSale	−13.2K sh	$20.34	−$268K	4,155,405
2021-07-01	TPSTTempest Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,635 sh	—	—	6,635
2021-07-01	TPSTTempest Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,635 sh	—	—	6,635
2021-06-25	TPSTTempest Therapeutics, Inc.A Award	Director	AAward	+580K sh	—	—	579,710
2021-06-24	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.3K sh	—	—	14,250
2021-03-30	DSGNDesign Therapeutics, Inc.C Conversion	Director	CConversion	+4.44M sh	—	—	4,439,839
2021-03-30	DSGNDesign Therapeutics, Inc.C Conversion	Director	CConversion	+281K sh	—	—	4,720,830
2021-03-30	DSGNDesign Therapeutics, Inc.P Purchase	Director	PPurchase	+10K sh	$20.00	+$200K	4,730,830
2021-03-30	DSGNDesign Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−7.24M sh	—	—	0
2021-03-30	DSGNDesign Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−458K sh	—	—	0
2021-03-25	DSGNDesign Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-06-11	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.3K sh	—	—	14,250
2019-06-13	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2019-05-13	NXTCNextCure, Inc.C Conversion	Director	CConversion	+979K sh	—	—	978,570
2019-05-13	NXTCNextCure, Inc.P Purchase	Director	PPurchase	+125K sh	$15.00	+$1.88M	1,103,570
2019-05-13	NXTCNextCure, Inc. · Series B-2 Preferred StockC Conversion	Director	CConversion	−7.86M sh	—	—	0
2018-06-22	ARMO BioSciences, Inc.U Disposition from Tender	Director	UDisposition from Tender	−405K sh	$50.00	−$20.2M	0
2018-06-22	ARMO BioSciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18K sh	$10.03	−$181K	0
2018-03-26	ARMO BioSciences, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2018-01-30	ARMO BioSciences, Inc.C Conversion	Director	CConversion	+405K sh	—	—	404,900
2018-01-30	ARMO BioSciences, Inc.Series C-1 Convertible Preferred StockC Conversion	Director	CConversion	−405K sh	—	—	0

Recent filings

Accepted (ET)
Jun 24
Xu Stella0001209191-23-033785
SEC(opens sec.gov)
Jun 164
Xu Stella0001209191-22-037525
SEC(opens sec.gov)
Mar 224
Xu Stella0001209191-22-020637
SEC(opens sec.gov)
Sep 204/A
Xu Stella0001179110-21-008866
SEC(opens sec.gov)
Jul 64
Xu Stella0001140361-21-023544
SEC(opens sec.gov)
Jun 294
Xu Stella0001140361-21-022786
SEC(opens sec.gov)
Jun 284
Xu Stella0001567619-21-012670
SEC(opens sec.gov)
Apr 14
Xu Stella0001209191-21-024234
SEC(opens sec.gov)
Mar 294
Xu Stella0001209191-21-023472
SEC(opens sec.gov)
Jun 154
Xu Stella0001123292-20-000885
SEC(opens sec.gov)
Jun 174
Xu Stella0001123292-19-000886
SEC(opens sec.gov)
May 134
Xu Stella0001123292-19-000750
SEC(opens sec.gov)

Companies

Address

C/O QUAN CAPITAL UGLAND HOUSE, PO BOX 309

GRAND CAYMAN, E9, KYI-1104